Frank, Rimerman Advisors LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1977560
Palo Alto, CA
Position in ALNY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$369,664
-$45,908 QoQ
Shares Held
1,228
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#520
of 784 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Frank, Rimerman Advisors LLC holds $4,627,199 across 8 Biotechnology names. ALNY ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,373 | $1,675,470 | |
| 2 | ARGX |
Argenx SE
|
649 | $602,122 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,493 | $588,342 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,807 | $460,437 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,228 | $369,664 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
570 | $355,417 | |
| 7 | INCY |
Incyte Corp
|
2,682 | $304,031 | |
| 8 | MRNA |
Moderna, Inc.
|
3,880 | $271,716 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $369,664 | 1,228 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $415,572 | 1,256 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $497,062 | 1,250 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $570,456 | 1,251 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $400,112 | 1,227 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||